Lv21
150 积分 2024-07-23 加入
Epigenome editing technologies for discovery and medicine
12天前
已完结
NMOSD and MOGAD: an evolving disease spectrum
12天前
已完结
Prime editing: advances and therapeutic applications
14天前
已完结
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions
17天前
已完结
Targeting REGNASE-1 programs long-lived effector T cells for cancer therapy
23天前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
24天前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
1个月前
已完结
Tumour antigen spreading mediated by vaccine-boosted CAR T cells
1个月前
已完结
Targeting metabolism to regulate immune responses in autoimmunity and cancer
1个月前
已完结
Next-generation CAR T cell therapies for glioblastoma
1个月前
已完结
皖公网安备34019202002308
